BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10655333)

  • 1. Fluorometric assessment of In vitro antidermatophytic activities of antimycotics based on their keratin-penetrating power.
    Okeke CN; Tsuboi R; Kawai M; Ogawa H
    J Clin Microbiol; 2000 Feb; 38(2):489-91. PubMed ID: 10655333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
    Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
    Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antifungal activities of amorolfine against fresh isolates from patients with cutaneous mycosis].
    Uchida K; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 Sep; 44(9):1007-12. PubMed ID: 1960850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the in vitro susceptibility pattern of clinical isolates of Trichophyton mentagrophytes and Trichophyton rubrum in Santiago, Chile].
    Díaz Jarabrán MC; Díaz González P; Espinoza Rodríguez J; Carrillo Muñoz AJ
    Rev Iberoam Micol; 2015; 32(2):83-7. PubMed ID: 24794211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Activity of Antifungal Drugs Against Trichophyton rubrum and Trichophyton mentagrophytes spp. by E-Test Method and Non-supplemented Mueller-Hinton Agar Plates.
    Intra J; Sarto C; Mazzola S; Fania C; Tiberti N; Brambilla P
    Mycopathologia; 2019 Aug; 184(4):517-523. PubMed ID: 31297668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
    Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
    Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of Trichophyton rubrum microspores in large quantities and its application to evaluate amorolfine/azole compound interactions in vitro.
    Laurent A; Monod M
    Mycoses; 2017 Sep; 60(9):581-586. PubMed ID: 28480990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method using micropig stratum corneum in vitro for the evaluation of anti-Trichophyton mentagrophytes activity.
    Nakashima T; Nozawa A; Majima T
    Microbiol Immunol; 2002; 46(8):521-5. PubMed ID: 12363015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum.
    Fernández-Torres B; Vázquez-Veiga H; Llovo X; Pereiro M; Guarro J
    Chemotherapy; 2000; 46(6):390-4. PubMed ID: 11053904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection.
    Schaller M; Borelli C; Berger U; Walker B; Schmidt S; Weindl G; Jäckel A
    Med Mycol; 2009 Nov; 47(7):753-8. PubMed ID: 19888808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antidermatophytic activity of saperconazole, a new fluorinated triazole.
    Fu KP; Isaacson DM; Lococo J; Foleno B; Hilliard J
    Drugs Exp Clin Res; 1992; 18(11-12):443-6. PubMed ID: 1308468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains].
    Solgun G; Fındık D; Türk Dağı H; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):159-67. PubMed ID: 21341170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes.
    Santos DA; Barros ME; Hamdan JS
    J Clin Microbiol; 2006 Jan; 44(1):98-101. PubMed ID: 16390955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes.
    Esteban A; Abarca ML; Cabañes FJ
    Med Mycol; 2005 Feb; 43(1):61-6. PubMed ID: 15712608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
    Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
    Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANTIFUNGAL POTENTIAL OF PLANT SPECIES FROM BRAZILIAN CAATINGA AGAINST DERMATOPHYTES.
    Biasi-Garbin RP; Demitto Fde O; Amaral RC; Ferreira MR; Soares LA; Svidzinski TI; Baeza LC; Yamada-Ogatta SF
    Rev Inst Med Trop Sao Paulo; 2016; 58():18. PubMed ID: 27007561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of susceptibility/resistance to antifungal drugs of Trichophyton mentagrophytes isolates by a macrodilution method.
    Barros ME; Hamdan JS
    Can J Microbiol; 2005 Nov; 51(11):983-7. PubMed ID: 16333338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study.
    Tahiliani S; Saraswat A; Lahiri AK; Shah A; Hawelia D; Shah GK; Girdhar M; Rao PN; Raghav PA; Agarwal P; Kharkar RD; Gupta RP; Udare S; Hegde S; Haldar S
    Indian J Dermatol Venereol Leprol; 2021; 87(6):800-806. PubMed ID: 34160163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of Cleome gynandra L. aerial parts for topical treatment of Tinea capitis: an in vitro evaluation.
    Imanirampa L; Alele PE
    BMC Complement Altern Med; 2016 Jul; 16():194. PubMed ID: 27391957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis.
    Tabata Y; Takei-Masuda N; Kubota N; Takahata S; Ohyama M; Kaneda K; Iida M; Maebashi K
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1035-9. PubMed ID: 26643333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.